Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | KREMEN1 |
Upstream (Parents) |
---|
(<<) BCL2L13 → KREMEN1 |
(<<) CACNA1E → KREMEN1 |
(<<) CDC42EP2 → KREMEN1 |
(<<) CYP1A2 → KREMEN1 |
(<<) EPHB2 → KREMEN1 |
(<<) ERBB2 → KREMEN1 |
(<<) FAM83A → KREMEN1 |
(<<) GRK5 → KREMEN1 |
(<<) HPCAL1 → KREMEN1 |
(<<) HSPA8 → KREMEN1 |
(<<) JUNB → KREMEN1 |
(<<) LIMK2 → KREMEN1 |
(<<) MIA3 → KREMEN1 |
(<<) MLXIPL → KREMEN1 |
(<<) MMP25 → KREMEN1 |
(<<) MYCN → KREMEN1 |
(<<) NGFR → KREMEN1 |
(<<) SEMA3A → KREMEN1 |
(<<) SPRY4 → KREMEN1 |
(<<) ST3GAL1 → KREMEN1 |
(<<) THRA → KREMEN1 |
(<<) TRIB1 → KREMEN1 |
(<<) WNT7B → KREMEN1 |
Downstream (Children) |
---|
KREMEN1 → CPD (>>) |
KREMEN1 → DNAJA4 (>>) |
KREMEN1 → FAM46B (>>) |
KREMEN1 → LRCH4 (>>) |
KREMEN1 → RBP1 (>>) |
KREMEN1 → RPS6KB1 (>>) |
KREMEN1 → SP5 (>>) |